Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EKF Launches Rapid Strip-Based Test for Hemoglobin at ISBT

Published: Tuesday, June 04, 2013
Last Updated: Monday, June 03, 2013
Bookmark and Share
Quick and easy determination of anemia using STAT-Site M Hgb.

EKF Diagnostics has announced the global launch of a new strip-based test for quick and easy hemoglobin analysis for anemia determination.

STAT-Site M Hgb, a hand-held analyzer that combines low cost per test with portability, will be introduced at ISBT (International Society of Blood Transfusion), Amsterdam, 2-5 June 2013, Stand 128.

STAT-Site M Hgb is a pocket-sized device that reliably delivers accurate hemoglobin analysis results within 30 seconds from 15 µL of finger-prick whole blood.

This hemoglobin photometer is maintenance-free, and whilst guarantees optimum performance and reliability. Intuitive, step by step on-screen instructions minimize training and ensures ease of use.

Due to its durability, portability and user-friendliness, STAT-Site M Hgb is especially suited to blood screening programmes in developing world markets, but it also has a niche in settings where operators are mobile.

Using just one 3V Li type battery for every 1,000 tests and with an operating temperature range of 16° to 35°C, the analyzer is ideal for field use.

At ISBT, EKF will also be demonstrating its Hemo Control (sold as HemoPoint H2 in USA and Asia) hemoglobin analyzer designed to provide quantitative, lab quality results (imprecision < 2%) within 25 seconds for blood banks, hospitals and clinics.

From one simple test this portable and robust analyzer delivers results for both hemoglobin and hematocrit and, new for 2013, includes Hemo Control Light pre-loaded data management software.

The software enables users to connect directly to hospital and laboratory information systems.

Hemo Control uses unique patented microcuvette technology - the NXT microcuvette. This enables precise and easy blood collection and significantly reduces the risk of air bubbles appearing in blood samples.

By minimizing occurrences of air bubbles in a sample, the NXT microcuvette ensures less waste and therefore reduces cost.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EKF Diagnostics’ Growth Drives New Role Creation
Expanding business welcomes new faces to further strengthen IVD expertise and new product development.
Saturday, July 18, 2015
EKF Diagnostics Collaborates with Joslin Diabetes Center
Supporting the ongoing clinical and commercial development of early Diabetic Kidney Disease biomarkers.
Monday, November 17, 2014
Studies Validate EKF Diagnostics’ Early Stage Test for Progressive DKD
Independent scientific evidence confirms novel sTNFR1/2 biomarkers can accurately predict end-stage renal disease, up to 10 years in advance.
Friday, May 23, 2014
New Clinical Diagnostics Distributor Program Enhances EKF Customer Service
EKF Diagnostics appoints Simona Carnielli as new EMEA Distribution Manager.
Thursday, May 08, 2014
EKF Diagnostics Acquires Selah Genomics and DiaSpect Medical
Combined with the recent acquisition of Seperation Technology the purchases strengthen EKF’s product and services offering.
Tuesday, April 22, 2014
EKF Diagnostics Acquires Separation Technology
Acquisition complements EKF’s existing offering in the hemoglobin testing market place.
Thursday, March 27, 2014
PointMan™ Enriches Low-level DNA Mutations from Whole Blood
Ultra-sensitive PointMan™ enables blood sampling instead of tissue biopsies for cancer patient mutation status assessment.
Wednesday, January 22, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!